MPG.eBooks - Search Results

201

Point-of-care tests for infectious diseases : a review of clinical and cost-effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technology in Health, Canadian Electronic Library

Read Now

202

MALDI-TOF mass spectrometry for pathogen identification : a review of accuracy and clinical effectiveness

Published 2015

CADTH Rapid Response SErvice

Read Now

203

Efinaconazole for fungal nail infections : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

204

Sufentanil for palliative pain relief : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Read Now

205

Streptococcal antigen test for pneumonia detection : a review of clinical and cost-effectiveness and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Read Now

206

CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...The Canadian Drug Expert Committee (CDEC) recommends that dapagliflozin not be listed...”

Read Now

207

Personal electronic health records : a review of clinical effectiveness, cost-effectiveness, and guidelines

Published 2016

CADTH Rapid Response Service

Read Now

208

Crushed buprenorphine or buprenorphine-naloxone for opioid dependency : a review of the clinical effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

209

Composite resin filling materials : a review of safety, cost-effectiveness and guidelines : an update

Published 2015

Canadian Agency for Drugs and Technologies in Health

Read Now

210

Olopatadine for the treatment of allergic conjunctivitis : a review of the clinical efficacy, safety, and cost-effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

211

Medical marijuana for post-traumatic stress disorder : a review of clinical effectiveness and guidelines

Published 2017

Canadian Agency for Drugs and Technologies in Health

Read Now

212

Optimal therapy recommendation for the use of solvent/detergent-treated human plasma : pilot project

Published 2011

Canadian Agency for Drugs and Technologies in Health

“...Canadian jurisdictions (except Quebec) must make a decision on the provision of S/D plasma...”

Read Now

213

Pre-operative carbohydrate loading or hydration : a review of clinical and cost-effectiveness, and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

214

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion...

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that selexipag be reimbursed for long...”

Read Now

215

Anticoagulation monitoring and reversal strategies for dabigatran, rivaroxaban, and apixaban : a review of clinical effectiveness

Published 2012

Canadian Agency for Drugs and Technologies in Health

Read Now

216

Aripiprazole for patients with bipolar disorder : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

217

Extracorporeal membrane oxygenation for acute respiratory failure : a review of the clinical effectiveness and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Read Now

218

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

“...The CADTH Canadian Drug Expert Committee (CDEC) recommends that tenofovir alafenamide (TAF...”

Read Now

219

CADTH Canadian Drug Expert Committee recommendation: Onasemnogene abeparvovec (Zolgensma...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...Recommendation: The CADTH Canadian Drug Expert Committee (CDEC) recommends that onasemnogene...”

Read Now

220

Anticoagulation monitoring and reversal strategies for dabigatran, rivaroxaban, and apixaban : a review of clinical effectiveness

Published 2012

Canadian Agency for Drugs and Technologies in Health

Narrow Search